Pharmaceutical companies in the
Top 100 continue to dominate in
terms of revenue, but represent
62% for a total $747B, about equal
to last year’s percentage. Revenue
growth trends are a little off, with
73% up (compared to 78% last
year but only 62% the year before).
Four entries stayed the same, and
four more were new to the list.
Overall revenue total for the top
100 was $1.207 trillion dollars.
TOP 100 HEALTHCARE COMPANIES
Pharmaceutical, Medical Device, Biotechnology
Combing through our previous lists of the Top 50 Pharmaceutical, Medical Device and
Biotechnology companies, we have compiled 2018’s Top 100 Healthcare Companies list.
This year we find 40 pharmaceutical companies, 46 medical device (medtech) companies,
14 biotech companies and some new entries, including United Therapeutics and Hoya.
Johnson & Johnson and comes in strong again at #1, with Pfizer, Roche, and Novartis
holding their positions, and Sanofi jumping into the top 5, while Bayer has dropped a few
positions to below GSK. The big news is a medical device company appearing on the top
10 again this year, as Medtronic takes the #8 spot, up two from last year.
Revenue growth brings good news
as the trends continue to be on the
upswing with 78% of Top 100 revenues increasing as compared with
62% last year, and less than 50%
the prior year. Only 19 companies
went down in revenue in 2017. The
total revenue added by medical
device was $42B, $16B by pharma
and $6B by biotech.
Companies are ranked by their
2017 revenue as furnished by their
annual reports and publicly available sources, Edgar and Morning-star stock information websites
(figures of non-U.S. companies
were converted to U.S. dollars
from various currencies using
end of the year exchange rates for
2017). Companies are categorized
by their predominant revenue
source and their own characterization per publicly available sources.
CLICK HERE TO GET TOP